🇺🇸
United States · US · US:50242-108_e8a259ac-2a09-4026-823c-f23cbcba6a2b
Rituxan Hycela
UNIISPLATC L01FA
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerGenentech, Inc.
CountryUS (United States)
ATC codeL01FA
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1150242108011 VIAL, SINGLE-DOSE in 1 CARTON (50242-108-01) / 11.7 mL in 1 VIAL, SINGLE-DOSE
- ndc1150242108861 VIAL, SINGLE-DOSE in 1 CARTON (50242-108-86) / 11.7 mL in 1 VIAL, SINGLE-DOSE
Annotations
UNII (FDA Substance ID)
743QUY4VD8
HYALURONIDASE (HUMAN RECOMBINANT)
RxCUI 1300478
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "743QUY4VD8",
"rxcui": "1300478",
"inchikey": null,
"display_name": "HYALURONIDASE (HUMAN RECOMBINANT)",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"3e5b7e82-f018-4eaf-ae78-d6145a906b20": {
"match": "brand_token",
"title": "RITUXAN HYCELA (RITUXIMAB AND HYALURONIDASE) INJECTION, SOLUTION [GENENTECH, INC.]",
"spl_version": "21",
"published_date": "2025-12-19"
}
},
"productid": "50242-108_e8a259ac-2a09-4026-823c-f23cbcba6a2b",
"productndc": "50242-108",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "HYALURONIDASE (HUMAN RECOMBINANT); RITUXIMAB",
"proprietary_name": "Rituxan Hycela",
"active_ingred_unit": "U/mL; mg/mL",
"application_number": "BLA761064",
"marketing_category": "BLA",
"nonproprietary_name": "rituximab and hyaluronidase",
"start_marketing_date": "20170622",
"active_numerator_strength": "2000; 120"
}Related drugs
Other records sharing ATC code L01FA.
Access this data programmatically
Query Rituxan Hycela and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.